Lack of myostatin results in excessive muscle growth but impaired force generation
- PMID: 17267614
- PMCID: PMC1794294
- DOI: 10.1073/pnas.0604893104
Lack of myostatin results in excessive muscle growth but impaired force generation
Erratum in
- Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4240
Abstract
The lack of myostatin promotes growth of skeletal muscle, and blockade of its activity has been proposed as a treatment for various muscle-wasting disorders. Here, we have examined two independent mouse lines that harbor mutations in the myostatin gene, constitutive null (Mstn(-/-)) and compact (Berlin High Line, BEH(c/c)). We report that, despite a larger muscle mass relative to age-matched wild types, there was no increase in maximum tetanic force generation, but that when expressed as a function of muscle size (specific force), muscles of myostatin-deficient mice were weaker than wild-type muscles. In addition, Mstn(-/-) muscle contracted and relaxed faster during a single twitch and had a marked increase in the number of type IIb fibers relative to wild-type controls. This change was also accompanied by a significant increase in type IIB fibers containing tubular aggregates. Moreover, the ratio of mitochondrial DNA to nuclear DNA and mitochondria number were decreased in myostatin-deficient muscle, suggesting a mitochondrial depletion. Overall, our results suggest that lack of myostatin compromises force production in association with loss of oxidative characteristics of skeletal muscle.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Contractile properties of EDL and soleus muscles of myostatin-deficient mice.J Appl Physiol (1985). 2006 Sep;101(3):898-905. doi: 10.1152/japplphysiol.00126.2006. Epub 2006 May 18. J Appl Physiol (1985). 2006. PMID: 16709649 Free PMC article.
-
Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle.Muscle Nerve. 2005 Jan;31(1):34-40. doi: 10.1002/mus.20175. Muscle Nerve. 2005. PMID: 15468312
-
Muscle growth after postdevelopmental myostatin gene knockout.Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E985-91. doi: 10.1152/ajpendo.00531.2006. Epub 2006 Dec 5. Am J Physiol Endocrinol Metab. 2007. PMID: 17148752
-
Growth factors controlling muscle development.Domest Anim Endocrinol. 1999 Oct;17(2-3):191-7. doi: 10.1016/s0739-7240(99)00036-3. Domest Anim Endocrinol. 1999. PMID: 10527122 Review.
-
Role of myostatin in metabolism.Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):451-7. doi: 10.1097/01.mco.0000134365.99523.7f. Curr Opin Clin Nutr Metab Care. 2004. PMID: 15192449 Review.
Cited by
-
Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.Skelet Muscle. 2016 Apr 4;6:14. doi: 10.1186/s13395-016-0085-7. eCollection 2016. Skelet Muscle. 2016. PMID: 27047655 Free PMC article.
-
Myostatin dysfunction does not protect from fasting-induced loss of muscle mass in mice.J Musculoskelet Neuronal Interact. 2019 Sep 1;19(3):342-353. J Musculoskelet Neuronal Interact. 2019. PMID: 31475942 Free PMC article.
-
Lack of Tgfbr1 and Acvr1b synergistically stimulates myofibre hypertrophy and accelerates muscle regeneration.Elife. 2022 Mar 24;11:e77610. doi: 10.7554/eLife.77610. Elife. 2022. PMID: 35323108 Free PMC article.
-
Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders.Curr Opin Support Palliat Care. 2013 Dec;7(4):352-60. doi: 10.1097/SPC.0000000000000013. Curr Opin Support Palliat Care. 2013. PMID: 24157714 Free PMC article. Review.
-
Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength.Am J Physiol Endocrinol Metab. 2014 Apr 15;306(8):E965-74. doi: 10.1152/ajpendo.00008.2014. Epub 2014 Feb 25. Am J Physiol Endocrinol Metab. 2014. PMID: 24569593 Free PMC article.
References
-
- McPherron AC, Lawler AM, Lee SJ. Nature. 1997;387:83–90. - PubMed
-
- Lee SJ. Annu Rev Cell Dev Biol. 2004;20:61–86. - PubMed
-
- Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ. N Engl J Med. 2004;350:2682–2688. - PubMed
-
- Ferrell RE, Conte V, Lawrence EC, Roth SM, Hagberg JM, Hurley BF. Genomics. 1999;62:203–207. - PubMed
-
- Wagner KR, McPherron AC, Winik N, Lee SJ. Ann Neurol. 2002;52:832–836. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
